Quest Diagnostics, Inc.

NYSE:DGX   3:59:50 PM EDT
143.07
+1.27 (+0.90%)
Other Pre-Announcement

Quest Diagnostics Sees FY2021 Reported Diluted EPS $11.48 To $12.18

Published: 07/22/2021 10:53 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook.
Establishes Full Year 2021 Outlook.
Q2 Reported Diluted EPS of $4.96.
Qtrly Adjusted Diluted EPS of $3.18.
Q2 Revenues of $2.55 Billion, Up 39.5% From 2020.
Sees 2021 Capital Expenditures Approximately $400 Million.
Sees FY 2021 Net Revenues $9.54 Billion to $9.79 Billion.
Sees 2021 Adjusted Diluted EPS $10.65 - $11.35.
Q2 Earnings per Share View $2.87, Revenue View $2.38 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2021 Earnings per Share View $11.14, Revenue View $9.49 Billion -- Refinitiv Ibes Data (analyst estimates).
Sees FY 2021 Reported Diluted EPS $11.48 to $12.18.